Standard

The role of S-bond in tenoxicam keto-enolic tautomerization. / Arkhipov, Sergey G.; Sherin, Peter S.; Kiryutin, Alexey S. et al.

In: CrystEngComm, Vol. 21, No. 36, 28.09.2019, p. 5392-5401.

Research output: Contribution to journalArticlepeer-review

Harvard

Arkhipov, SG, Sherin, PS, Kiryutin, AS, Lazarenko, VA & Tantardini, C 2019, 'The role of S-bond in tenoxicam keto-enolic tautomerization', CrystEngComm, vol. 21, no. 36, pp. 5392-5401. https://doi.org/10.1039/c9ce00874h

APA

Vancouver

Arkhipov SG, Sherin PS, Kiryutin AS, Lazarenko VA, Tantardini C. The role of S-bond in tenoxicam keto-enolic tautomerization. CrystEngComm. 2019 Sept 28;21(36):5392-5401. doi: 10.1039/c9ce00874h

Author

BibTeX

@article{de960f5d20ba4e178cadfc17c0658012,
title = "The role of S-bond in tenoxicam keto-enolic tautomerization",
abstract = "A non-steroidal anti-inflammatory drug, 4-hydroxy-2-methyl-N-2-pyridyl-2H-thieno(2,3-e)-1,2-thiazine-3-carboxamide 1,1-dioxide, called tenoxicam (TXM), with important implications in cancer treatment, has a peculiarity with respect to other molecules from the oxicam family. TXM is predominantly found in the zwitterionic form (ZWC) within the crystal structures of pure compounds and their solvates; however, it can be present in the β-keto-enolic form (BKE) or β-diketone (BDK) form. To understand this phenomenon, the combined effects of environment (solvent) and intra-molecular non-covalent interactions on the TXM keto-enol tautomerization were investigated through a combined experimental and computational study. We found that the polarity of a solvent had a minor influence on the crystallization process; this allowed to us synthesize and solve six new solvates with TXM in the ZWC form. Careful investigation of the non-covalent interactions between the sulphur atom of thiophenyl moiety and oxygen of the carbonyl group (S-bond) through a computational approach with the natural bond orbital (NBO) theory has shown that TXM crystallization is modulated by the S-bond. This study further confirms the importance of the S-bond in the drug design; however, nowadays, it is still underestimated.",
keywords = "CRYSTAL-STRUCTURE, CO-CRYSTALS, MELOXICAM, COCRYSTALS, PHARMACOKINETICS, SOLUBILITY",
author = "Arkhipov, {Sergey G.} and Sherin, {Peter S.} and Kiryutin, {Alexey S.} and Lazarenko, {Vladimir A.} and Christian Tantardini",
year = "2019",
month = sep,
day = "28",
doi = "10.1039/c9ce00874h",
language = "English",
volume = "21",
pages = "5392--5401",
journal = "CrystEngComm",
issn = "1466-8033",
publisher = "Royal Society of Chemistry",
number = "36",

}

RIS

TY - JOUR

T1 - The role of S-bond in tenoxicam keto-enolic tautomerization

AU - Arkhipov, Sergey G.

AU - Sherin, Peter S.

AU - Kiryutin, Alexey S.

AU - Lazarenko, Vladimir A.

AU - Tantardini, Christian

PY - 2019/9/28

Y1 - 2019/9/28

N2 - A non-steroidal anti-inflammatory drug, 4-hydroxy-2-methyl-N-2-pyridyl-2H-thieno(2,3-e)-1,2-thiazine-3-carboxamide 1,1-dioxide, called tenoxicam (TXM), with important implications in cancer treatment, has a peculiarity with respect to other molecules from the oxicam family. TXM is predominantly found in the zwitterionic form (ZWC) within the crystal structures of pure compounds and their solvates; however, it can be present in the β-keto-enolic form (BKE) or β-diketone (BDK) form. To understand this phenomenon, the combined effects of environment (solvent) and intra-molecular non-covalent interactions on the TXM keto-enol tautomerization were investigated through a combined experimental and computational study. We found that the polarity of a solvent had a minor influence on the crystallization process; this allowed to us synthesize and solve six new solvates with TXM in the ZWC form. Careful investigation of the non-covalent interactions between the sulphur atom of thiophenyl moiety and oxygen of the carbonyl group (S-bond) through a computational approach with the natural bond orbital (NBO) theory has shown that TXM crystallization is modulated by the S-bond. This study further confirms the importance of the S-bond in the drug design; however, nowadays, it is still underestimated.

AB - A non-steroidal anti-inflammatory drug, 4-hydroxy-2-methyl-N-2-pyridyl-2H-thieno(2,3-e)-1,2-thiazine-3-carboxamide 1,1-dioxide, called tenoxicam (TXM), with important implications in cancer treatment, has a peculiarity with respect to other molecules from the oxicam family. TXM is predominantly found in the zwitterionic form (ZWC) within the crystal structures of pure compounds and their solvates; however, it can be present in the β-keto-enolic form (BKE) or β-diketone (BDK) form. To understand this phenomenon, the combined effects of environment (solvent) and intra-molecular non-covalent interactions on the TXM keto-enol tautomerization were investigated through a combined experimental and computational study. We found that the polarity of a solvent had a minor influence on the crystallization process; this allowed to us synthesize and solve six new solvates with TXM in the ZWC form. Careful investigation of the non-covalent interactions between the sulphur atom of thiophenyl moiety and oxygen of the carbonyl group (S-bond) through a computational approach with the natural bond orbital (NBO) theory has shown that TXM crystallization is modulated by the S-bond. This study further confirms the importance of the S-bond in the drug design; however, nowadays, it is still underestimated.

KW - CRYSTAL-STRUCTURE

KW - CO-CRYSTALS

KW - MELOXICAM

KW - COCRYSTALS

KW - PHARMACOKINETICS

KW - SOLUBILITY

UR - http://www.scopus.com/inward/record.url?scp=85072305090&partnerID=8YFLogxK

U2 - 10.1039/c9ce00874h

DO - 10.1039/c9ce00874h

M3 - Article

AN - SCOPUS:85072305090

VL - 21

SP - 5392

EP - 5401

JO - CrystEngComm

JF - CrystEngComm

SN - 1466-8033

IS - 36

ER -

ID: 21609205